Antisoma PLC to Present at 11th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference in New York

LONDON and CAMBRIDGE, MA--(Marketwire - February 03, 2009) - Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive, Glyn Edwards, will be presenting at the 11th Annual BIO CEO & Investor Conference in New York on Monday, 9th February at 10:30am EST/3:30pm GMT.

A webcast of the presentation will be available on Antisoma’s website at http://www.antisoma.com/asm/media/webcast/

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com for further information about Antisoma.

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.


Enquiries:
Daniel Elger
VP, Marketing & Communications
Antisoma plc
+44 7909 915 068

MORE ON THIS TOPIC